Antineoplastic combinations comrising a rapamycin dderiovative and an aromatse inhibitor

Details for Australian Patent Application No. 2004218439 (hide)

Owner Wyeth

Inventors Friedman, Robert; Sherman, Matthew L.; Berger, Mark; Maguire, Robert T.; Gibbons, James J. Jr.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004218439

PCT Pub. Number WO2004/078133

Priority 60/452,289 05.03.03 US

Filing date 1 March 2004

Wipo publication date 16 September 2004

International Classifications

A61K 031/436

Event Publications

29 September 2005 PCT application entered the National Phase

  PCT publication WO2004/078133 Priority application(s): WO2004/078133

3 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004218443-Method for modifying pH within meat products

2004218430-Posh interacting proteins and related methods